NYLIM WMC Value Class C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
NYLIM WMC Value Class C MMPCX
- NAV / 1-Day Return 22.26 / +0.59 %
- Total Assets 871.4M
-
Adj. Expense Ratio
1.980%
- Expense Ratio 1.980%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.92%
- Turnover 43%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MMPCX
Will MMPCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Microsoft Corp | 6.77 | 62M | Technology |
JPMorgan Chase & Co | 3.53 | 32M | Financial Services |
Merck & Co Inc | 2.78 | 25M | Healthcare |
Johnson & Johnson | 2.70 | 25M | Healthcare |
Cisco Systems Inc | 2.04 | 19M | Technology |
UnitedHealth Group Inc | 2.01 | 18M | Healthcare |
Elevance Health Inc | 1.82 | 17M | Healthcare |
Intercontinental Exchange Inc | 1.80 | 16M | Financial Services |
Gilead Sciences Inc | 1.80 | 16M | Healthcare |
Pfizer Inc | 1.77 | 16M | Healthcare |